![](/img/cover-not-exists.png)
The BRAF Status May Predict Response to Sorafenib in Gastrointestinal Stromal Tumors Resistant to Imatinib, Sunitinib, and Regorafenib: Case Series and Review of the Literature
Franck, Caspar, Rosania, Rosa, Franke, Sabine, Haybaeck, Johannes, Canbay, Ali, Venerito, MarinoLanguage:
english
Journal:
Digestion
DOI:
10.1159/000490886
Date:
September, 2018
File:
PDF, 388 KB
english, 2018